Dextenza intraocular and NovoLog FlexPen
Determining the interaction of Dextenza intraocular and NovoLog FlexPen and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexamethasone ophthalmic
Brand name: Dextenza, Dexycu, Ozurdex, Maxidex
Synonyms: Dextenza (intraocular), Dextenza Insert
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dextenza intraocular-Novolog Injection
- Dextenza intraocular-NovoLog Mix 70/30
- Dextenza intraocular-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens))
- Dextenza intraocular-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Vials))
- Dextenza intraocular-NovoLog Mix 70/30 FlexPen
- Dextenza intraocular-NovoLog PenFill
- NovoLog FlexPen-Dextran 40
- NovoLog FlexPen-Dextran 70 6% in 5% Dextrose high molecular weight
- NovoLog FlexPen-Dextran 75
- NovoLog FlexPen-Dextran high molecular weight
- NovoLog FlexPen-Dextranomer and Hyaluronate Derivatives (Deflux)
- NovoLog FlexPen-Dextranomer and Hyaluronate Derivatives (Solesta)